Edition:
India

Aspen Pharmacare Holdings Ltd (APNJ.J)

APNJ.J on Johannesburg Stock Exchange

31,177.00ZAc
21 Nov 2017
Change (% chg)

-- (--)
Prev Close
31,177.00
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
1,052,550
52-wk High
32,750.00
52-wk Low
25,564.00

Summary

Name Age Since Current Position

Kuseni Dlamini

49 2017 Non-Executive Chairman of the Board

Stephen Saad

53 2014 Group Chief Executive, Executive Director

Michael Attridge

56 Deputy Group Chief Executive, Executive Director

Riaan Verster

41 2013 Company Secretary & Group Governance Officer

Roy Andersen

69 2010 Lead Independent Non-Executive Director

Christopher Mortimer

56 1999 Non-Executive Director

David Redfern

51 2015 Non-Executive Director

Maureen Manyama-Matome

40 2014 Independent Non-Executive Director

Babalwa Ngonyama

43 2016 Non-Executive Independent Director

Sindiswa Zilwa

50 2006 Non-Executive Independent Director

Biographies

Name Description

Kuseni Dlamini

Mr. Kuseni Douglas Dlamini is an Independent Non-Executive Chairman of the Board of Aspen Pharmacare Holdings Limited. with effect from 7 December 2015. He holds MPhil (Oxon); BSocSci (Hons), (Natal). Kuseni is a graduate of the University of Natal, Durban, and Oxford where he was a Rhodes Scholar. Kuseni was previously Chief Executive Officer of Old Mutual South Africa and Emerging Markets. He brings a wealth of economic and business skills to the Board having previously held positions as the Head of Anglo American South Africa and Executive Chairman of Richards Bay Coal Terminal Company. Kuseni currently serves as Chairman of the South African National Parks (SANParks). He is a former member of the Global Agenda Council on Economic Growth and Poverty Alleviation formed by the World Economic Forum. He is active in academic and professional bodies which include the Council of the University of Pretoria, South African Institute of International Affairs (SAIIA) and the advisory boards of the Wits Business School and Common Purpose.

Stephen Saad

Mr. Stephen Bradley Saad, CA(SA), is a Group Chief Executive, Executive Director of Aspen Pharmacare Holdings Ltd.

Michael Attridge

Mr. Michael Guy Attridge, CA(SA), is a Deputy Group Chief Executive, Executive Director of Aspen Pharmacare Holdings Ltd. He is also a member of the Social & Ethics Committee and attends meetings of all of the other Board Committees by invitation.

Riaan Verster

Mr. Riaan Verster is a Company Secretary & Group Governance Officer of Aspen Pharmacare Holdings Ltd. He hlods BProc, LLB, LLM (Labour Law), ACIS.

Roy Andersen

Mr. Roy Cecil Andersen, CA(SA), CPA (Texas), is a Lead Independent Non-Executive Director of Aspen Pharmacare Holdings Limited. He is a Chartered Accountant by profession and with significant experience in the banking, insurance, construction and packaging industries, Roy’s expertise in fields such as governance and remuneration have been of great benefit to Aspen. He was previously Chairman and Chief Executive of Ernst & Young, Chief Executive of the Liberty Group Limited and a former President of JSE Limited. Roy is currently a non-executive director of Nampak Limited, Chairman of SASFIN Limited and SASFIN Bank Limited and a Major General in the South African National Defence Force, holding the post of Chief of Defence Reserves. He is a member of the King Committee on Corporate Governance. Roy serves as lead independent non-executive director and is the Chairman of the Remuneration & Nomination Committee and a member of the Audit & Risk Committee.

Christopher Mortimer

Mr. Christopher Nattle Mortimer, BA, LLB, is a Non-Executive Director of Aspen Pharmacare Holdings Ltd., since January 1999. He has been a full-time practising attorney since 1988 and has substantial legal and commercial expertise. His intimate knowledge of the Group, its business operations and governance processes has been of immense benefit to Aspen over the years and he continues to serve the Board as a trusted adviser. As Chris’ firm is intermittently called upon to provide legal advice to the Group, he is classified as a non-independent executive director.

David Redfern

Mr. David Redfern is a Non-Executive Director of the Company. David is GSK's Chief Strategy Officer and the Chairman of ViiV Healthcare Limited. His extensive expertise in the international pharmaceutical industry is expected to add value to Aspen.

Maureen Manyama-Matome

Ms. Maureen Manyama-Matome is an Independent Non-Executive Director of the Company. effective June 1, 2014. Maureen is a CA (SA) and currently the Financial Director of the Airports Company of South Africa. Prior to this, she was the Chief Financial Officer of the South African Forestry Company Limited. She is a non-executive of the South African Reserve Bank and serves on this bank's Audit Committee. She has also held directorships on a number of other boards during the past 9 years. Other than Maureen's B.Com Accounting (UCT), B.Compt Honours + CTA (Unisa) and B.Com Honours in Taxation (UP) degrees, she holds an MBA degree from the Gordon Institute of Business Science (GIBS).

Babalwa Ngonyama

Ms. Babalwa Ngonyama serves as Non-Executive Independent Director of the Company. Babalwa is a CA (SA) and currently the CEO of Sinayo Securities (Pty) Limited, a women owned and managed securities firm. Prior to this she was the Group Chief Internal Auditor of Nedbank Limited, an audit partner at Nkonki Chartered Accountants and, thereafter, a partner at Deloitte (Financial Institutions Services Team). She is, amongst others, a non-executive director and member of the audit committees of Barloworld Limited, Implats Limited and Group Five Limited. Other than Babalwa’s B.Com Accounting (Transkei), B.Compt Honours + CTA (Transkei), she holds an MBA degree from Bond University and a Higher Diploma in Banking Law (RAU). She also completed the Women in Leadership Programme at Harvard University (Boston) in 2008.

Sindiswa Zilwa

Ms. Sindiswa Victoria Zilwa is a Non-Executive Independent Director of Aspen Pharmacare Holdings Ltd., She is a Chartered Accountant by profession, is an expert in the areas of accounting, auditing and business management. She is currently the Chief Executive Officer of Nkonki Incorporated. Sindi is a Chartered Director (SA) and has had vast experience as a director in the public and private sectors and currently serves as a non-executive director of Discovery Holdings Limited, Metrofile Limited and Gijimi Limited. She is an author of “The ACE Model-Winning Formula for Audit Committees”, used by the Institute of Directors to train audit committee members in South Africa. She is a member of the South African Institute of Chartered Accountants and Independent Regulatory Board for Auditors. Sindi was previously Non-Executive Chairman of Airports Company South Africa and a non-executive director of Woolworths Limited, Primedia Limited, Wiphold Limited, Ethos Private Equity, Institute of Directors, Alexkor Limited, Rebosis Limited, ATNS SOC Limited and previously chaired the BUSA Standing Committee on Transformation.

Basic Compensation

Name Fiscal Year Total

Kuseni Dlamini

1,036,000

Stephen Saad

16,506,000

Michael Attridge

13,583,000

Riaan Verster

--

Roy Andersen

629,000

Christopher Mortimer

320,000

David Redfern

313,000

Maureen Manyama-Matome

575,000

Babalwa Ngonyama

520,000

Sindiswa Zilwa

701,000
As Of  30 Jun 2017